SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Speciality Chemicals Ltd (OMKARCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533317 NSE: OMKARCHEM Chemicals | Small Cap | Omkar SpecialityChem Share Price

₹3.60 0.00 (0.00%)

As on 28-Apr'26 16:59

Omkar Speciality Chemicals Ltd (OMKARCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533317 NSE: OMKARCHEM Chemicals | Small Cap | Omkar SpecialityChem Share Price

₹3.60 0.00 (0.00%)

As on 28-Apr'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹3.6
52-Week Low / High
₹4 / 8
TTM EPS
₹-128.5
TTM Sales
₹19.4 Cr.
Book Value per Share
-
P/E Ratio
0.00
Industry PE
52.2
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.02
Lower than its 5-year historical median
EV/EBITDA
-43.46
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Underperforms industry median
Return on Capital Employed (ROCE)
12.40%
In line with industry median
Return on Assets (ROA)
2.36%
Operating Profit Margin
16.4%
Net Profit Margin
4.46%
Gross Profit Margin
5.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-20.68%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
14.71%
Pledged shares (%) of Promoter's holding (%)
56.73%
Reserves
₹-194 Cr.
Equity
₹1 Cr.
Face Value
₹10
All Time Low / High
₹2.27 / 249.10

Omkar Speciality Chemicals stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Omkar Speciality Chemicals Ltd a good quality company?
Omkar Speciality Chemicals Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Omkar Speciality Chemicals Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Omkar Speciality Chemicals Ltd vs industry peers?
Omkar Speciality Chemicals Ltd revenue CAGR is -31.54%, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Omkar Speciality Chemicals Ltd?
Promoters hold 14.71% of the Omkar Speciality Chemicals Ltd, with 56.73% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Omkar Speciality Chemicals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -32.3% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Omkar Speciality Chemicals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 19.5%17%12.1%10.1%14.1%-42.2%-70.4%3.3%-8.4%12.4%-
Value Creation
Index
0.40.2-0.1-0.30.0-4.0NANANANA-

Growth Parameters

Sales 16720221019330031719242.756.945.119
Sales YoY Gr.-20.7%4%-7.8%55.2%5.6%-39.5%-77.7%33.4%-20.7%-
Adj EPS 8.410.37.68.911.42.2-33.4-12-7-0.4-128.5
YoY Gr.-23.2%-26.6%17.7%27.1%-80.6%-1617.3%NANANA-
BVPS (₹) 53.962.868.579.288.2-1.4-60.8-72-79-76.90
Adj Net
Profit
16.520.314.918.423.44.5-68.7-24.7-14.5-0.8-13
Cash Flow from Ops. -0.40.124.152.9-14.1107261.44-16.4-
Debt/CF from Ops. -215.8960.56.43.3-13.21.79166.558.1-13.9-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales -13.5%-31.5%-38.3%-20.7%
Adj EPS -171.5%-151.5%NANA
BVPS-204%-197.3%NANA
Share Price -31.7% -17.7% -24.9% -51.9%

Key Financial Parameters

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on
Equity %
16.617.511.312.213.65.1107.418.19.30.5334
Op. Profit
Mgn %
19.91815.915.415.718.1-22.6-4.40.216.4-2237.5
Net Profit
Mgn %
9.910.17.19.57.81.4-35.9-58-25.4-1.9-68.4
Debt to
Equity
0.711.21.11-64.2-1.9-1.6-1.4-1.40
Working Cap
Days
21423929534124223021325320535435,789
Cash Conv.
Cycle
911261571541024843-31-50-3525,940

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Sales166.95201.53209.62193.31300.02316.74191.5942.6556.8845.12
Operating Expenses + 133.75165.20176.72164.37254.61259.43234.9544.5357.1237.75
Manufacturing Costs8.4114.0611.6511.828.527.9311.086.235.476.41
Material Costs114.34136.36147.17134.28227.59236.40210.4228.4044.4326.83
Employee Cost 5.506.929.888.338.237.753.033.492.781.96
Other Costs 5.507.868.039.9510.287.3410.436.424.442.56
Operating Profit 33.1936.3332.9028.9445.4157.31-43.36-1.88-0.247.37
Operating Profit Margin (%) 19.9%18.0%15.7%15.0%15.1%18.1%-22.6%-4.4%-0.4%16.3%
Other Income + 3.705.795.754.918.752.253.693.040.450.86
Exceptional Items 00-0.0700-163.62-52.599.9304.04
Interest 8.107.4311.7511.4316.5221.8326.1314.624.935.57
Depreciation 5.625.686.101.974.2810.908.167.996.593.56
Profit Before Tax 23.182920.7320.4533.36-136.79-126.55-11.52-11.313.15
Tax 6.738.206.132.5111.15-27.43-22.585.353.321.14
Profit After Tax 16.4520.8014.6017.9322.21-109.36-103.97-16.87-14.642.01
PAT Margin (%) 9.9%10.3%7.0%9.3%7.4%-34.5%-54.3%-39.6%-25.7%4.5%
Adjusted EPS (₹)8.410.67.48.710.8-53.1-50.5-8.2-7.11.0
Dividend Payout Ratio (%)14.90%14.20%20.20%17.20%13.90%0%0%0%0%0%

Valuation of Omkar SpecialityChem - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21

Equity and Liabilities

Shareholders Fund + 105.83123.21134.37162.95181.44-2.82-125.09-148.08-162.49-158.34
Share Capital 19.6319.6319.6320.5820.5820.5820.5820.5820.5820.58
Reserves 86.21103.59114.74142.37160.87-23.39-145.66-168.66-183.07-178.91
Debt +73.84116.39148.22162.50174.72169.52222.72219.50223.31218.09
Long Term Debt4.6829.9037.2141.8079.2357.9076.4074.3273.8366.63
Short Term Debt69.1786.49111.01120.6995.49111.62146.32145.18149.48151.46
Minority Interest0000000000
Trade Payables25.2627.1238.0735.4450.52119.2518.2120.1517.9810.24
Others Liabilities 11.7215.8221.1927.7240.057.034.345.0411.2110.33
Total Liabilities 216.67282.55341.85388.59446.73292.99120.1896.6190.0280.33

Fixed Assets

Net Fixed Assets +36.2944.4642.7268.3077.9082.5076.1468.4353.1427.91
Gross Block46.6060.4664.8192.37106.2593.3595.2395.2278.5844.04
Accumulated Depreciation10.311622.0924.0728.3510.8519.0926.7925.4416.13
CWIP 30.6540.1968.52107.35112.6700000
Investments 2.1210.8613.8013.8013.910.5711.070.350.380.71
Inventories52.6663.5662.9754.6661.7871.014.332.903.831.32
Trade Receivables38.4961.4785.1568.10102.2678.1910.308.694.6613.73
Cash Equivalents 31.4021.5718.1112.236.6310.581.460.170.400.26
Others Assets 25.0540.4250.5864.1671.5750.1516.8916.0827.6036.39
Total Assets 216.67282.55341.85388.59446.73292.99120.1896.6190.0280.33

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Cash Flow From Operating Activity + -0.360.1224.1452.85-14.08107.3025.961.384.02-16.41
PBT 23.182920.8020.4533.36-136.79-126.55-11.52-11.313.15
Adjustment 10.319.7414.949.8613.47187.0790.5111.5614.404.61
Changes in Working Capital -27.86-32.96-4.6623.67-58.5150.2762.551.330.93-24.17
Tax Paid -5.98-5.67-6.93-1.13-2.416.75-0.56000
Cash Flow From Investing Activity + -31.99-45.35-43.30-75.8716.53-119.90-64.3310.901.5117.35
Capex -34.42-23.40-32.67-66.39-19.21-60.53-54.38-0.121.5017.23
Net Investments 000-00.1213.78-10.301100
Others 2.42-21.95-10.62-9.4835.62-73.150.360.020.010.11
Cash Flow From Financing Activity + 22.2935.8315.3217.33-7.9115.7535.24-13.55-5.30-1.08
Net Proceeds from Shares 00010.69000000
Net Proceeds from Borrowing -3.6025.227.3111.8237.4200-10.98-0.37-0.06
Interest Paid -8.10-7.43-13.09-11.43-16.52-15.83-15.86-2.57-4.93-1.01
Dividend Paid -2.29-2.85-3.42-3.44-3.61-3.720000
Others 36.2720.8824.529.69-25.2035.3051.10-00-0
Net Cash Flow -10.07-9.40-3.84-5.69-5.463.16-3.13-1.280.23-0.14

Financial Ratio

PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Ratios
ROE (%)16.6118.1611.3412.0612.9N/AN/AN/AN/AN/A
ROCE (%)19.4616.9912.110.1114.14N/AN/AN/AN/AN/A
Asset Turnover Ratio0.910.860.720.570.760.930.960.390.610.53
PAT to CFO Conversion(x)-0.020.011.652.95-0.63N/AN/AN/AN/A-8.16
Working Capital Days
Receivable Days67.8084.70118.90135.4097.5095.5081.7081.3042.9074.40
Inventory Days85.3098.50102.60103.9066.6070.2069.6030.9021.6020.80
Payable Days74.8070.1080.9099.9068.90131.10119.20246.60156.60192

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *76.9476.9476.9476.9476.9476.9463.8963.8956.7356.73
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Omkar Speciality Chemicals Ltd FAQs

The current trading price of Omkar SpecialityChem on 28-Apr-2026 16:59 is ₹3.60.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Apr-2026 the market cap of Omkar SpecialityChem stood at ₹0.37 Cr

The latest P/E ratio of Omkar SpecialityChem as of 27-Apr-2026 is 0.00.

The latest P/B ratio of Omkar SpecialityChem as of 27-Apr-2026 is 0.00.

The 52-week high of Omkar SpecialityChem is ₹8.10 and the 52-week low is ₹3.59.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Omkar SpecialityChem is ₹19.36 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Omkar Speciality Chemicals Ltd is a below average quality company.

The key valuation ratios of Omkar Speciality Chemicals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Omkar Speciality Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Omkar Speciality Chemicals Ltd

Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of Speciality Chemicals and Intermediates for Chemical and Allied Industries. It has four units at MIDC, Badlapur (East), District - Thane, Maharashtra. The company was originally incorporated as Omkar Speciality Chemicals on February 24, 2005 and took over business of the Proprietorship Firm Omkar Chemicals which was in operation since 1983 with Pravin S Herlekar as the Proprietor. The private limited company was converted into a public limited company on March 18, 2010.

It manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates. The Inorganic Intermediates include Molybdenum derivatives, Selenium derivatives, Iodine derivatives, Cobalt derivatives, Bismuth & Tungsten derivatives and the organic intermediates include Tartaric acid derivatives and other intermediates. These products find applications in various industries like Pharmaceutical Industry, Chemical Industry, Glass Industry, Cosmetics, Ceramic Pigments and Cattle & Poultry Feeds.  The company exports its products to Europe, Canada, Asia, South America and Australia. The total exports constituted 8.69%, 12.35% and 7.97% of gross sales during FY 2008, FY 2009 and FY 2010 respectively. The chemical maker’s association with leading organizations in India and abroad has enabled it to broaden the business, to expand the existing product range and to develop new molecules as per the specific demands of its valued customers.

Omkar Speciality Chemicals has basic research capabilities and has recently acquired Rishichem Research as a wholly-owned subsidiary which is expected to provide a total R&D back-up to the company for all its future expansion and diversification programmes.

Plant and Machinery

The company’s manufacturing facilities have plant and machinery, which includes stainless steel reactors, glass lined reactors, stainless steel centrifuges, glassline centrifuges, nutsche filters, agitated filter nutsches, tray dryers, fluid bed dryers, blenders and support equipments like boilers, chilling plants, cooling tower, etc.

UnitProducts manufacturedExisting sanctioned load
Unit No.1   Iodine, Selenium,Molybdenum compounds and other derivatives73 KW (LT)
Unit No.2Iodine, Selenium,Molybdenum compounds and other derivatives377 KW (HT)
Unit No.3  Selenium Sulphide286 KW (HT)
Unit No.4  Warehouse and proposed manufacturing unit15 KW (LT)
Total751 KW

Product Portfolio

The company manufactures a range of organic, inorganic and organo inorganic intermediates. Organic intermediates are compounds rich in carbon molecules. Inorganic intermediates are compounds rich in metallic molecules. Organo inorganic intermediates are combination of carbon and metal molecules. The various products manufactured by the company in various categories are as follows:

CategoryApplications
Inorganic intermediates
Molybdenum DerivativesElectroplating, Lubricant, Water treatment chemicals
Selenium DerivativesFlucloronide, Shampoo, Pharma Intermediates, Tinted float glass, Glass industry

Iodine Derivatives

Photographic chemicals, 2- Methoxyestradiol, Nylon tyre yarn, Binfloxacin, Zaleplon, Hexestrol, Etiroxate, Idoxuridine, Rizatriptan,Adapalene, Dabelotine, Fluticasone Propionate, Pharma Intermediates, Terfenadine, Metalaxyl, Lamivudine, Alprazolam

Cobalt Derivatives

Electroplating and synthetic fibres, Ceramic pigment, Refining industry, Silica gel, Ceramic industry, Batteries, Electroplating, Cattle and Poultry feeds

Bismuth DerivativesPharma Intermediates, Auto paints, Soft Ferrites, Electronic, Cosmetics, Pharma and Anti ulcer drug
Tungsten DerivativesPharma industry
Organic intermediates
Tartaric Acid DerivativesResolving agent
Other IntermediatesDolasetron Mesylate, Terbinafine, Pioglitazone, Roziglitazone, Azoxystrobin, Seldinafen, Pharma Intermediates
Organo inorganic intermediates

Idoxifene, Benodanil, Etofenamate, Closentel, Rafoxanide, Pharma Intermediates, OPC, Electronic, Lamivudine, Orlistat, Anti DiabiticDrug, Finasteride, Rimexolone, Montelukast, Cerivastatin Sodium, Tocapone, Fluconazole, Nebirolol, Lansoprazole, Rabeprazole

Milestones

  • 1983 - Formation of Omkar Chemicals with capacity of 6 MT per annum for manufacture of molybdenum derivatives
  • 2005 - The existing company takes over Omkar Chemicals. At the time of takeover, the installed capacity was 318 MT and the product range was cobalt, selenium & iodine derivatives in addition to molybdenum derivatives
  • 2006-07 - The company expands the total installed capacity to 325 MT
  • 2007-08 - The company further augments capacity to 375 MT
  • 2009 - The company sets up a new manufacturing facility at MIDC, Badlapur viz. Unit 2 with an installed capacity of 375 MT. Following setting up of this unit, its total installed capacity doubles to 750 MT.
  • Recently, Omkar Speciality Chemicals established a new manufacturing facility at B-34, MIDC, Badlapur, Thane, Maharashtra viz. Unit 3 with an installed capacity of 200 MT. With the set up of Unit 3, the company’s total installed capacity stands increased to 950 MT
  • 2010 - Omkar Speciality Chemicals becomes a public limited company
  • 2010 - The company acquires 99.82% stake in Rishichem Research and makes it wholly-owned subsidiary
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: